中国医药工业杂志2023,Vol.54Issue(11) :1601-1606.DOI:10.16522/j.cnki.cjph.2023.11.009

射银咽炎颗粒的制备工艺和含量测定

Preparation Process and Content Determination of Sheyin Pharyngitis Granules

梁健 吴轶 刘丹政 许龙 沈熊
中国医药工业杂志2023,Vol.54Issue(11) :1601-1606.DOI:10.16522/j.cnki.cjph.2023.11.009

射银咽炎颗粒的制备工艺和含量测定

Preparation Process and Content Determination of Sheyin Pharyngitis Granules

梁健 1吴轶 1刘丹政 2许龙 3沈熊1
扫码查看

作者信息

  • 1. 复旦大学附属中山医院药剂科,上海 200032
  • 2. 复旦大学附属中山医院耳鼻喉科,上海 200032
  • 3. 合肥创新医药技术有限公司,安徽合肥 230088
  • 折叠

摘要

该研究采用流化床法制备射银咽炎颗粒,以流化床雾化压力、流化温度和喷液速率为考察指标,颗粒合格率(即粒径180~2 000 μm颗粒占总量的比例)和溶化时间为评价指标,采用Box-Behnken设计优化工艺参数,并采用高效液相色谱-二极管阵列检测(HPLC-DAD)法测定颗粒剂中绿原酸、哈巴苷、哈巴俄苷、次野鸢尾黄素的含量.结果显示,优化条件为雾化压力22 kPa,进风温度66 ℃,喷液速率1.55 mL/min,所得颗粒的合格率和溶化时间分别为91.51%和42.87 s.颗粒剂中绿原酸、哈巴苷、哈巴俄苷、次野鸢尾黄素的含量分别为3.22、0.72、0.63和0.16 mg/g.

Abstract

The study utilized a fluidized bed method to prepare Sheyin pharyngitis granules.The Box-Behnken design was used to optimize the process parameters,with the fluidized bed atomization pressure,fluidization temperature,and spray liquid rate as the investigation indicators,and the qualification rate(namely the proportion of the granules with the particle size of 180-2 000 μm to total granules)and dissolution time as the evaluation indicators.Additionally,the high-performance liquid chromatography method coupled with a diode array detector(HPLC-DAD)was established to determine contents of chlorogenic acid,harpagide,harpagoside and irisflorentin in the granules.The results indicated that the optimized process parameters were as follows:an atomization pressure of 22 kPa,an inlet air temperature of 66 ℃,and a spray liquid rate of 1.55 mL/min.The qualification rate and dissolution time of the obtained granules were 91.51%and 42.87 s,respectively.The contents of chlorogenic acid,harpagide,harpagoside and irisflorentin in the granules were 3.22,0.72,0.63 and 0.16 mg/g,respectively.

关键词

射银咽炎颗粒/流化床/Box-Behnken设计/绿原酸/哈巴苷/哈巴俄苷/次野鸢尾黄素

Key words

Sheyin pharyngitis granules/fluidized bed/Box-Behnken design/chlorogenic acid/harpagide/harpagoside/irisflorentin

引用本文复制引用

基金项目

上海市临床重点专科建设项目(shslczdzk06504)

出版年

2023
中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCDCSCD
影响因子:0.487
ISSN:1001-8255
参考文献量14
段落导航相关论文